Phase I Trial of a PSA Based Vaccine and an Anti-CTLA-4 Antibody in Adults With Metastatic Androgen Independent Prostate Cancer.
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Rilimogene galvacirepvec (Primary) ; Rilimogene glafolivec (Primary) ; Ipilimumab; Sargramostim
- Indications Prostate cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 10 Oct 2016 According to a Bavarian Nordic media release, results from this trial were presented at 2015 Genitourinary Cancers Symposium 2015.
- 24 Feb 2015 According to a Bavarian Nordic media release, data from this trial will be presented at the 2015 Genitourinary Cancers Symposium.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History